Office of Research on Women's Health: National Institutes of Health and the Women's Health Agenda

1994 ◽  
Vol 736 (1 Forging a Wom) ◽  
pp. 196-204 ◽  
Author(s):  
JUDITH H. LaROSA
Keyword(s):  
Women’S Health ◽  
Women's Health ◽  
National Institutes Of Health ◽  
Health Agenda

Office of Research on Women's Health National Institutes of Health

1996 ◽  
Vol 5 (4) ◽  
pp. 317-323 ◽  
Author(s):  
MARY T. CHUNKO ◽  
EUGENE HAYUNGA ◽  
KAREN ROTHENBERG ◽  
JOYCE RUDICK ◽  
VIVIAN W. PINN
Keyword(s):  
Women’S Health ◽  
Women's Health ◽  
National Institutes Of Health

NIH and the Women's Health Agenda

1995 ◽  
Vol 1 (3-4) ◽  
pp. 137-143
Author(s):  
Judith H. LaRosa
Keyword(s):  
Women’S Health ◽  
Women's Health ◽  
Health Agenda

scholarly journals As precision medicine becomes more important, is it finally time for increased emphasis on gender medicine?

2017 ◽  
Vol 39 (1) ◽  
pp. 4-5
Author(s):  
Jane F. Reckelhoff ◽  
Licy L. Yanes Cordozo
Keyword(s):  
Clinical Trials ◽  
Precision Medicine ◽  
Women’S Health ◽  
Women's Health ◽  
European Commission ◽  
Health Research ◽  
National Institutes Of Health ◽  
Gender Medicine ◽  
Grant Proposals ◽  
Set Up

Gender medicine is the topic of this issue of The Biochemist. In 2014, Francis Collins, Director of the National Institutes of Health (NIH), and Janine Clayton, Director of the Office of Research on Women's Health (ORWH) at NIH, announced that NIH would begin requiring all preclinical grant proposals to address sex as a biological variable1. The ORWH was set up in 1990 with the specific mandate to promote the inclusion of women and minority individuals in all clinical trials going forward2. Similar guidelines are imposed by the European Commission and the Canadian Institutes of Health Research.

Sign in / Sign up

Export Citation Format

Share Document